Torbay Pharma focuses on research, development, manufacturing and marketing of injectable, terminally sterilised generic pharmaceutical products for secondary care. We work as CDMO/CMO for some of the worlds largest pharmaceutical companies, with a significant presence is the North American market.
Additionally, Torbay has a wide portfolio of injectable products, both licensed and unlicensed and is looking for partners in and outside of Europe for the distribution and marketing of those products.
Torbay's key areas of focus are the continued development of our CDMO/CMO business and the licensing and out-licensing of our existing and pipeline of injectable medicines.